24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Dr. Uzair Chaudhary graduated from the Aga Khan Medical College and completed his residency program at the Indiana University School of Medicine. Then, he did a fellowship at the UCSF . Dr. Chaudhary is specialized in Hematology and board certified in Hematology and Medical Oncology. He has been in practice for more than 20 years and is affiliated with the Saint Agnes Medical Center, UCSF Medical Center, Fresno Heart and Surgical Hospital, and Community Regional Medical Center. During his career, he has also contributed to several clinical research publications.
AetnaBlue Cross of CaliforniaBlue Shield of CaliforniaCignaFirst Health PPOHealth NetHumanaMultiPlanUnited Healthcare
Aga Khan Medical College
Medical School
Indiana University School of Medicine
Residency
UCSF
Fellowship
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
Community Regional Medical Center
Languages: English/Spanish
(559) 459-6000
2823 Fresno St
Fresno, California 93721 
Fresno Heart & Surgical Hospital
Languages: English/Spanish
(559) 433-8000
15 E. Audubon Drive
Fresno, California 93720
Saint Agnes Medical Center
Languages: English/Spanish
(559) 450-3000
1303 E Herndon Ave
Fresno, California 93720
UCSF Medical Center
Languages: English/Spanish
(415) 353-1037
505 Parnassus Ave
San Francisco, California 94143
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or un...
Esnaola, N. F.,Chaudhary, U. B.,O'Brien, P.,Garrett-Mayer, E.,Camp, E. R.,Thomas, M. B.,Cole, D. J.,Montero, A. J.,Hoffman, B. J.,Romagnuolo, J.,Orwat, K. P.,Marshall,...; Int. J. Radiat. Oncol. Biol. Phys.. 2014 Mar 13.
See more >>
Chemotherapeutic and targeted biological agents for metastatic bladder cancer: A comprehensive review.
Sio, T. T.,Ko, J.,Gudena, V. K.,Verma, N.,Chaudhary, U. B.; Int. J. Urol.. 2014 Jan 25.
See more >>
Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image-Guided Intensity-Modulated Radiotherapy for Localized High-Risk Prostate Adenocarcinoma.
Marshall, D. T.,Ramey, S.,Golshayan, A. R.,E Keane, T.,Kraft, A. S.,Chaudhary, U.; Clin Genitourin Cancer. 2014 Jan 01.
See more >>
Hospitals & Clinics
specialties & services